On the Record · Abiomed
Abiomed competitors, on the record
The companies Abiomed itself names as competitors in its annual reports, 2020 to 2022, each with the sentence it appears in and the filing it came from.
Who Abiomed names
| Company | Named in |
|---|---|
| Abbott Laboratories | 2022 |
| Boston Scientific | 2022 |
| Cardiovascular Systems Inc. | 2022 |
| Edwards Lifesciences | 2022 |
| Getinge (Maquet Cardiovascular) | 2022 |
| LivaNova | 2022 |
| Medtronic | 2022 |
| Teleflex | 2022 |
| Terumo Heart | 2022 |
In its own words
Abbott Laboratories, Boston Scientific, Cardiovascular Systems Inc., Edwards Lifesciences, Getinge (Maquet Cardiovascular), LivaNova, Medtronic, Teleflex, Terumo Heart
Word for word“In addition, there are a number of companies, including Cardiovascular Systems Inc., Abbott Laboratories, Medtronic, Edwards Lifesciences, Boston Scientific, LivaNova, Terumo Heart, Teleflex, Getinge (Maquet Cardiovascular) and several early-stage companies, that are developing medical devices that provide circulatory support and oxygenation, including implantable left ventricular assist devices, miniaturized rotary ventricular assist devices and cardiopulmonary bypass devices that directly and indirectly compete with our products.” 10-K for 2022
Read from Abiomed’s annual reports (10-K for 2022, 10-K for 2021, 10-K for 2020) and the financial data it files with the SEC, as of 2022-05-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.